Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #228386 on Biotech Values
DewDiligence
01/23/20 5:42 PM
#228387 RE: jq1234 #228386
GILD is testing its oral PD-L1 inhibitor, GS-4224 for both solid tumors and HBV.